RE:RE:RE:RE:RE:RE:RE:Back to our regularly scheduled program
My prediction is...once 90 test participants are reached, if there is not a serious possibility that in the following three to six months that the test will be stopped, or if Baxter doesn't approach Spectral management with talk about Baxter buyig Spectral, that at the next General Shareholder meeting in June, the Board will once again ask shareholders to approve a 1 : 10 reverse stock split and seek a U.S. listing by the end of the summer or early fall..
I don't think we would need a 1 : 20 reverse split like what has been requeted by the Board in the past because I think the share price will be about $1 U.S. by the end of June as the result of "exceeding" expectations which will definitely be disclosed, plus the Baxter milestone payment, plus PR that will emerge in the U.S. that Spectral will be seeking a U.S. listing.